Cart
sales@molnova.com
4-Amino-3-hydroxybutyric Acid
CAS No. 924-49-2
4-Amino-3-hydroxybutyric Acid( —— )
Catalog No. M16625 CAS No. 924-49-2
Agent for improving learning or memory [US6803366]Gamma Hydroxybutyric Acid, commonly abbreviated GHB, is a therapeutic drug which is illegal in multiple countries.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 36 | In Stock |
|
| 100MG | 58 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 142 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Amino-3-hydroxybutyric Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionAgent for improving learning or memory [US6803366]Gamma Hydroxybutyric Acid, commonly abbreviated GHB, is a therapeutic drug which is illegal in multiple countries.
-
DescriptionAgent for improving learning or memory [US6803366]Gamma Hydroxybutyric Acid, commonly abbreviated GHB, is a therapeutic drug which is illegal in multiple countries. It is currently regulated in the US and sold by Jazz Pharmaceuticals under the name Xyrem.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetGAT
-
RecptorGABAR| GHB receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number924-49-2
-
Formula Weight119.12
-
Molecular FormulaC4H9NO3
-
Purity>98% (HPLC)
-
SolubilitySoluble in Water
-
SMILESNCC(O)CC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Candela M, et al. J Chromatogr A. 2000 Aug 25;890(2):273-80.
molnova catalog
related products
-
Chloral hydrate
Chloral Hydrate is a synthetic monohydrate of chloral with sedative, hypnotic, and anticonvulsive properties.
-
TPA023
TPA023 is a potent, α2/α3 subtype-selective, and oral GABAA receptor agonist with Kd of 0.92, 1.05 and 0.58 nM for α1-, α2-, α3-, and α5-containing human receptors.
-
Flumazenil
Flumazenil(Ro 15-1788) is a benzodiazepine antagonist, non-selective for α1, α2, α3 or α5-containing GABAA receptors.
